the-companies

AT&T says Time Warner purchase could avoid FCC scrutiny

AT&T Inc expects to be able to bypass a powerful telecommunications regulator in its planned $85.4 billion acquisition of Time Warner Inc , the companies said in regulatory filings on Friday. Time Warner said that since it does not plan to transfer any Federal Communications Commission licenses to AT&T, it would likely not need FCC approval and would only need the consent of the U.S. Justice Department. AT&T could forego the FCC by unloading a Time Warner broadcast station,

More: 
AT&T says Time Warner purchase could avoid FCC scrutiny

the-companies

DuPont CEO Breen says Trump win unlikely to impact Dow deal

Executives and dealmakers are looking for signs of whether the incoming Trump administration will take a traditional Republican approach to major mergers and treat them with a lighter touch. Breen said he does not expect Trump's rhetoric would make the president-elect's administration

See the rest here:
DuPont CEO Breen says Trump win unlikely to impact Dow deal

the-companies

U.S. import prices post first drop in six months, but trend improving

U.S. import prices fell for the first time in six months in August on weak petroleum and food costs, but the declining trend is slowing as oil prices stabilize and the dollar's rally fades. Import prices slipped 0.2 percent last month after gaining 0.1 percent in July. August's drop was the first since February and was led by a 2.8 percent decline in petroleum prices.

Originally posted here: 
U.S. import prices post first drop in six months, but trend improving

the-companies

Bayer’s Monsanto acquisition to face politically charged scrutiny

WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over…

Go here to see the original: 
Bayer’s Monsanto acquisition to face politically charged scrutiny

the-companies

Bayer’s Monsanto acquisition to face politically charged scrutiny

WASHINGTON D.C./NEW YORK (Reuters) – As the global agricultural sector races to consolidate, Bayer AG's $66 billion all-cash deal to acquire Monsanto Co will test growing political and consumer unease in the United States and abroad over the future of food production. Bayer’s pesticide-focused agricultural business has few overlaps with Monsanto's dominant seed franchise, according to the companies' executives. Monsanto and Bayer “have chosen to do a deal …

See original here: 
Bayer’s Monsanto acquisition to face politically charged scrutiny

the-companies

Gawker Media founder to file for personal bankruptcy: source

By Jessica DiNapoli (Reuters) – Gawker Media founder and CEO Nick Denton will file for personal bankruptcy protection as early as Monday after losing a fight in a Florida court for a shield against a judgment in a breach of privacy case involving professional wrestler Hulk Hogan, according to a…

More: 
Gawker Media founder to file for personal bankruptcy: source

the-companies

SolarCity accepts Tesla’s $2.6 billion offer; both shares fall

SolarCity Corp agreed to Tesla Motors Inc's $2.6 billion offer to buy the solar panel installer, the companies said Monday, clearing one obstacle in the way of Elon Musk's ambitious plans for a carbon-free energy and transportation company. Tesla's stock swap offer valued SolarCity at $25.37 a share, or $200 million less than the initial proposal that Musk outlined in June, before advisers to the companies had done due diligence. SolarCity shares closed last Friday at about 5 percent above that

See more here:
SolarCity accepts Tesla’s $2.6 billion offer; both shares fall

the-companies

Teva says Allergan deal to close ‘any time’, expects U.S. antitrust clearance

NEW YORK/TEL AVIV (Reuters) – Teva Pharmaceutical Industries Ltd said on Wednesday it expected its $40 billion deal to buy Allergan Plc's generics business to close “at any time,” even as the companies extended the deadline for completing the transaction to October to allow more time for the U.S. antitrust review. “We …

See the original post here: 
Teva says Allergan deal to close ‘any time’, expects U.S. antitrust clearance

the-companies

U.S. Fed awards $23.24 billion in reverse repos

The Federal Reserve on Monday awarded $23.24 billion of one-day, fixed-rate reverse repurchase agreements to 17 bidders at an interest rate of 0.25 percent, the New York Fed said on its website. The reverse repurchase agreement

See the rest here: 
U.S. Fed awards $23.24 billion in reverse repos

the-companies

Exclusive: Medivation succumbs to pressure to explore sale -sources

U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to obtain confidential information about the company, the people said. Sanofi made its

Go here to read the rest:
Exclusive: Medivation succumbs to pressure to explore sale -sources

Next Page »